[{"Assets_0_Q2_USD":19746000.0,"CommonStockSharesOutstanding_0_Q2_shares":34176999.0,"NetIncomeLoss_1_Q2_USD":-67000.0,"NetIncomeLoss_2_Q2_USD":-7229000.0,"StockholdersEquity_0_Q2_USD":14762000.0,"Ticker":"EYPT","CIK":"1314102","name":"PSIVIDA CORP.","OfficialName":"EyePoint Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20161231","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408871503.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170209"}]